Rheumatology

Top Story

Rituximab biosimilar shows pharmacokinetic bioequivalence in patients with RA

June 24, 2016

GP2013, a proposed rituximab biosimilar, demonstrated pharmacokinetic bioequivalence to rituximab in patients with rheumatoid arthritis, according to results presented at the EULAR Annual Congress.

Researchers randomly assigned 173 patients with active rheumatoid arthritis (RA) refractory or intolerant to standard disease-modifying antirheumatic drugs and tumor necrosis factor inhibitors to GP2013 (Sandoz) or rituximab (Genentech/Biogen Idec). After week 24, 67.4% of patients in the GP2013 group and 64.4% of patients in the rituximab group received a second treatment course, results showed.

Meeting News Coverage

Many patients with RA experience sexual dysfunction

June 24, 2016
LONDON — According to a speaker at the EULAR Annual Congress, more than one-third of men and women with rheumatoid arthritis who are still sexually active have…

Rheumatoid arthritis may differ by location

June 24, 2016
Researchers recently discovered that cellular differences in joints are associated with joint-specific differences in rheumatoid arthritis. Investigators Wei Wang
In the Journals

Receipt of pharmaceutical industry-sponsored meal associated with increased prescription rate

June 23, 2016
Recent findings published in JAMA Internal Medicine showed that receipt of a pharmaceutical industry-sponsored meal was associated with increased prescription rates by…
Meeting News Coverage

CHS-0214 biosimilar shows equivalence in efficacy to etanercept

June 23, 2016
LONDON — A biosimilar to etanercept shows equivalence in efficacy at the primary endpoint and other measures, according to data presented at the EULAR Annual…
More News Headlines »
CME

Giant Cell Arteritis: New Findings on Diagnostic Strategies and Emerging Therapies

This activity is supported by an educational grant from Genentech, Inc.

Giant cell arteritis is a potentially debilitating rheumatologic disease that afflicts predominantly older men and…
More »
Video
Meeting News Coverage

VIDEO: Nowell speaks to Arthritis Power's focus on rheumatologic diseases

June 16, 2016
More »
Featured
EULAR Annual Congress 2016

EULAR Annual Congress 2016

CME

Use of a Bipolar Blood-Sealing System During Total Joint Arthroplasty: December 2015

The goal of the clinical use of a bipolar blood-sealing system is to reduce perioperative blood loss in total joint…
More »
Current Issues
View the Current Issue
Healio Rheumatology
morganatic-roan
morganatic-roan